Financhill
Sell
31

NVOS Quote, Financials, Valuation and Earnings

Last price:
$0.0000
Seasonality move :
-2.63%
Day range:
$0.0031 - $0.0031
52-week range:
$0.0001 - $0.0725
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
0.00x
Volume:
--
Avg. volume:
5.1K
1-year change:
-94.56%
Market cap:
$61.2K
Revenue:
$13.3M
EPS (TTM):
-$0.67

Earnings Data

Next earnings date for NVOS
--
Most recent earnings per share
$0.26
Beat by $0.26
(Aug 31/2024)
Consensus Estimate
--
(Aug 31/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NVOS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/31/2024 Q3 -- $3.1M $0.26 -- --
07/19/2024 Q2 -- $3.2M -$0.74 -- --
04/15/2024 Q1 -- $3.2M -$0.16 -- --
01/22/2024 Q4 -- $3.9M -$0.28 -- --
08/31/2023 Q3 -- $3.3M -$0.20 -- --
07/17/2023 Q2 -- $3.3M -$0.10 -- --
02/28/2023 Q1 -- $2.6M -$0.58 -- --
11/30/2022 Q4 -- $3.4M -$1.16 -- --
08/31/2022 Q3 -- -$8.1M -$7.58 -- --
07/14/2022 Q2 -- $13.9M -$1.28 -- --
04/13/2022 Q1 -- $2.9M -$1.67 -- --
01/18/2022 Q4 -- $3.2M -$0.67 -- --
08/31/2021 Q3 -- $2.7M -$0.73 -- --
07/14/2021 Q2 -- $2.4M -$0.16 -- --
04/15/2021 Q1 -- $2.1M -$0.56 -- --
01/13/2021 Q4 -- $2.2M -$0.33 -- --
08/31/2020 Q3 -- $1.8M -$1.80 -- --
07/14/2020 Q2 -- $1M -$0.04 -- --
04/20/2020 Q1 -- $2.4M -$0.22 -- --
11/30/2019 Q4 -- $2.5M -$0.04 -- --
08/31/2019 Q3 -- $2.4M $0.04 -- --
05/31/2019 Q2 -- $2.5M -$0.04 -- --
02/28/2019 Q1 -- $2.2M -$0.06 -- --
11/30/2018 Q4 -- $2.3M -$0.12 -- --
08/31/2018 Q3 -- $2.2M -$0.08 -- --
05/31/2018 Q2 -- $2.3M -$0.10 -- --
02/28/2018 Q1 -- $2.1M -$1.00 -- --
11/30/2017 Q4 -- $2.3M -$0.18 -- --
08/31/2017 Q3 -- $2.2M -$0.15 -- --
05/31/2017 Q2 -- $2.1M -$0.21 -- --
03/31/2017 Q1 -- -- -$0.16 -- --
12/31/2016 Q4 -- -- -$0.19 -- --
09/30/2016 Q3 -- -- -$0.17 -- --
06/30/2016 Q2 -- -- -$0.08 -- --
03/31/2016 Q1 -- -- -$0.31 -- --

Novo Integrated Sciences, Inc. Earnings Questions

  • How Much did Novo Integrated Sciences, Inc. Generate in Revenue Last Quarter?

    Novo Integrated Sciences, Inc. reported $3.1M worth of top line sales in its most recent quarter.

  • Did Novo Integrated Sciences, Inc. Beat Earnings Last Quarter?

    Novo Integrated Sciences, Inc. announced earnings per share of $0.26 which represents a beat of analyst forecast a -- per share.

  • Is Novo Integrated Sciences, Inc. Profitable?

    Novo Integrated Sciences, Inc. reported $1.3M that represents $0.08 per share over the last quarter.

  • What is the Analyst Consensus for Novo Integrated Sciences, Inc. EPS Next Year?

    Novo Integrated Sciences, Inc.'s earnings are forecast to grow from -$0.89 per share to -- per share next year representing an increase of --.

  • When is Novo Integrated Sciences, Inc.'s Earnings Date?

    Currently, Novo Integrated Sciences, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on May 16, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
77
CPS alert for Feb 14

Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.

Buy
58
TPH alert for Feb 14

Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.

Sell
20
IRON alert for Feb 14

Disc Medicine, Inc. [IRON] is down 21.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock